“We are very disappointed about this withdrawal as it is not in the best interests of people with diabetes. We think this is wrong and asked Novo Nordisk to reconsider their decision, considering the 90,000 or so people currently using Mixtard 30, but they argued they are committed to withdrawing all older types of human insulin over time.
“We then asked for a longer withdrawal period to ensure a properly co-ordinated response to this, but that proposal was also turned down.”
No comments:
Post a Comment